Onyx™ Liquid Embolic IDE Clinical Study
NCT: NCT06742801 · RECRUITING
NCT IDNCT06742801
StatusRECRUITING
Start Date2025-05-09
Completion2027-05
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.
Frequently Asked Questions
What is Onyx™ Liquid Embolic IDE Clinical Study?
Onyx™ Liquid Embolic IDE Clinical Study is a clinical trial registered under NCT06742801. Current status: RECRUITING.
What is the status of NCT06742801?
The current status of NCT06742801 (Onyx™ Liquid Embolic IDE Clinical Study) is: RECRUITING.
When did Onyx™ Liquid Embolic IDE Clinical Study start?
Onyx™ Liquid Embolic IDE Clinical Study started on 2025-05-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.